中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共41条,第1-10条 帮助

条数/页: 排序方式:
Inulin-like polysaccharide ABWW may impede CCl4 induced hepatic stellate cell activation through mediating the FAK/PI3K/AKT signaling pathway in vitro & in vivo 期刊论文  OAI收割
CARBOHYDRATE POLYMERS, 2024, 卷号: 326, 页码: 15
作者:  
Dai, Xiaolan;  Du, Zhenyun;  Jin, Can;  Tang, Bixi;  Chen, Xia
  |  收藏  |  浏览/下载:11/0  |  提交时间:2024/02/19
Structural insights into the interaction of three Y- shaped ligands with PI3Kα 期刊论文  OAI收割
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 卷号: 120, 期号: 34, 页码: 9
作者:  
Zhou, Qingtong;  Liu, Xiao;  Neri, Dario;  Li, Wenxin;  Favalli, Nicholas
  |  收藏  |  浏览/下载:8/0  |  提交时间:2023/12/08
Discovery of 4-oxo-4,5-dihydropyrazolo[1,5-a]quinoxaline-7-carboxamide derivatives as PI3K alpha inhibitors via virtual screening and docking-based structure optimization 期刊论文  OAI收割
BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 卷号: 86, 页码: 15
作者:  
Gu, Dongyan;  Zhang, Mengmeng;  Cai, Lvtao;  Wang, Chang;  Zhou, Yu -Bo
  |  收藏  |  浏览/下载:7/0  |  提交时间:2023/10/17
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors 期刊论文  OAI收割
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 卷号: 8, 期号: 1, 页码: 153
作者:  
Zhang, Xu
  |  收藏  |  浏览/下载:3/0  |  提交时间:2024/03/27
Targeting PI3K alpha overcomes resistance to KRas(G12C) inhibitors mediated by activation of EGFR and/or IGF1R 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 页码: 12
作者:  
Qi, Wei-liang;  Li, Hui-yu;  Wang, Yi;  Xu, Lan;  Deng, Jie-ting
  |  收藏  |  浏览/下载:15/0  |  提交时间:2023/04/10
Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3K alpha 期刊论文  OAI收割
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 卷号: 119, 期号: 46, 页码: 11
作者:  
Liu, Xiao;  Zhou, Qingtong;  Hart, Jonathan R.;  Xu, Yingna;  Yang, Su
  |  收藏  |  浏览/下载:16/0  |  提交时间:2023/10/17
Genome-wide gain-of-function screening identifies EZH2 mediating resistance to PI3K alpha inhibitors in oesophageal squamous cell carcinoma 期刊论文  OAI收割
CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 卷号: 12, 期号: 5, 页码: 17
作者:  
Xing, Hui;  Gao, Mengshi
  |  收藏  |  浏览/下载:47/0  |  提交时间:2022/08/16
Repressing MYC by targeting BET synergizes with selective inhibition of PI3K alpha against B cell lymphoma 期刊论文  OAI收割
CANCER LETTERS, 2022, 卷号: 524, 页码: 206-218
作者:  
Chen, Zi-qi;  Cao, Zhe-rui;  Wang, Yi;  Zhang, Xi;  Xu, Lan
  |  收藏  |  浏览/下载:54/0  |  提交时间:2021/12/16
CYH33  MYC  P300  BET  B cell lymphoma  PI3K  
SAF-248, a novel PI3K delta-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma 期刊论文  OAI收割
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 11
作者:  
Zhang, Xi;  Duan, Yu-ting;  Wang, Yi;  Zhao, Xing-dong;  Sun, Yi-ming
  |  收藏  |  浏览/下载:53/0  |  提交时间:2021/05/24
Adaptive resistance to PI3K alpha-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells 期刊论文  OAI收割
CELL DEATH & DISEASE, 2021, 卷号: 12, 期号: 1, 页码: 13
作者:  
Wang, Yu-xiang;  Zhang, Xu;  Ma, Qing-yang;  Hu, Lan-dian;  Zhang, Xi
  |  收藏  |  浏览/下载:42/0  |  提交时间:2021/05/24